1887

Journal of Medical Microbiology logo

Volume 68, Issue 2

Pertussis epidemiology in Tunisian infants and children and characterization of Bordetella pertussis isolates: results of a 9-year surveillance study, 2007 to 2016 Free

Abstract

Purpose. Pertussis remains a public health concern in most countries. Our study aimed to prospectively explore the epidemiology of pertussis in the Tunis area of Tunisia between 2007 and 2016, and to characterize the virulence-associated genes of the collected Bordetella pertussis isolates.

Methodology. Infants and children hospitalized at the Children’s Hospital of Tunis, Tunisia, between 2007 and 2016 for suspicion of pertussis were enrolled in the study. Culture and real-time PCR (qPCR) assays targeting IS481, IS1001, recA, H-IS1001 and ptxP were used to confirm the pertussis diagnosis. Phenotypic and genotypic characterization of recovered isolates was performed.

Results/Key findings. A total of 1844 children were included in the study. Overall, 306 children (16.6 %) with Bordetella infection were confirmed by qPCR. Among them, 265 (86.6 %) were confirmed as having B. pertussis (IS481+, ptxP+, H-IS1001−), 18 (5.9 %) as having Bordetella parapertussis (IS481−, IS1001+) and 11 (3.6 %) as having Bordetella spp. (IS481+, ptxP−, H-IS1001−). No Bordetella holmesii (IS481+, IS1001−, H-IS1001+) was identified. The estimated pertussis incidence in the Tunis area was 134/100 000 in children aged less than 5 years. Two epidemic peaks were observed in 2009 and 2014. Ten B. pertussis isolates were cultured and characterized. Deficiency in pertactin expression was not observed, and genotyping of the isolates revealed a predominant allelic profile: ptxP3-ptxA1-prn2-fim2-1-fim3-2.

Conclusion. This study demonstrated that pertussis is still present as a cyclical disease in Tunisia, despite high primo-vaccination coverage with a pertussis whole-cell vaccine. The predominant genotype of Tunisian B. pertussis isolates is similar to isolates circulating in countries using the acellular vaccine.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): Bordetella , epidemiology , genotyping , pertussis , surveillance and Tunisia
© 2019 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000892
2018-12-10
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jmm/68/2/241.html?itemId=/content/journal/jmm/10.1099/jmm.0.000892&mimeType=html&fmt=ahah

References

  1. Cherry JD. Pertussis: challenges today and for the future. PLoS Pathog 2013; 9:e1003418 [View Article][PubMed]
     [Google Scholar]
  2. Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011; 11:557–570 [View Article][PubMed]
     [Google Scholar]
  3. WHO Pertussis vaccines: WHO position paper, August 2015 - recommendations. Vaccine 2016; 34:1423–1425 [View Article][PubMed]
     [Google Scholar]
  4. Yeung KHT, Duclos P, Nelson EAS, Hutubessy RCW. An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect Dis 2017; 17:974–980 [View Article][PubMed]
     [Google Scholar]
  5. Guiso N, Wirsing von König CH. Surveillance of pertussis: methods and implementation. Expert Rev Anti Infect Ther 2016; 14:657–667 [View Article][PubMed]
     [Google Scholar]
  6. He Q, Barkoff AM, Mertsola J, Glismann S, Bacci S et al. High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance. Euro Surveill 2012; 17:20239 [View Article]
     [Google Scholar]
  7. Domenech de Cellès M, Magpantay FM, King AA, Rohani P. The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc Biol Sci 2016; 283:20152309 [View Article][PubMed]
     [Google Scholar]
  8. Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D et al. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio 2014; 5:e01074 [View Article][PubMed]
     [Google Scholar]
  9. de Gouw D, Hermans PW, Bootsma HJ, Zomer A, Heuvelman K et al. Differentially expressed genes in Bordetella pertussis strains belonging to a lineage which recently spread globally. PLoS One 2014; 9:e84523 [View Article][PubMed]
     [Google Scholar]
  10. Pawloski LC, Queenan AM, Cassiday PK, Lynch AS, Harrison MJ et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol 2014; 21:119–125 [View Article][PubMed]
     [Google Scholar]
  11. Bowden KE, Williams MM, Cassiday PK, Milton A, Pawloski L et al. Molecular epidemiology of the pertussis epidemic in Washington State in 2012. J Clin Microbiol 2014; 52:3549–3557 [View Article][PubMed]
     [Google Scholar]
  12. Quinlan T, Musser KA, Currenti SA, Zansky SM, Halse TA. Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004-2013. Mol Cell Probes 2014; 28:138–140 [View Article][PubMed]
     [Google Scholar]
  13. Miyaji Y, Otsuka N, Toyoizumi-Ajisaka H, Shibayama K, Kamachi K. Genetic analysis of Bordetella pertussis isolates from the 2008-2010 pertussis epidemic in Japan. PLoS One 2013; 8:e77165 [View Article][PubMed]
     [Google Scholar]
  14. Otsuka N, Han HJ, Toyoizumi-Ajisaka H, Nakamura Y, Arakawa Y et al. Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan. PLoS One 2012; 7:e31985 [View Article][PubMed]
     [Google Scholar]
  15. Tsang RS, Shuel M, Jamieson FB, Drews S, Hoang L et al. Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years. Int J Infect Dis 2014; 28:65–69 [View Article][PubMed]
     [Google Scholar]
  16. Lam C, Octavia S, Ricafort L, Sintchenko V, Gilbert GL et al. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis 2014; 20:626–633 [View Article][PubMed]
     [Google Scholar]
  17. Barkoff AM, Mertsola J, Pierard D, Dalby T, Hoegh SV et al. Surveillance of circulating Bordetella pertussis strains in Europe during 1998 to 2015. J Clin Microbiol 2018; 56:e01998-17 [View Article][PubMed]
     [Google Scholar]
  18. Martin SW, Pawloski L, Williams M, Weening K, Debolt C et al. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Clin Infect Dis 2015; 60:223–227 [View Article][PubMed]
     [Google Scholar]
  19. Safarchi A, Octavia S, Luu LD, Tay CY, Sintchenko V et al. Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model. Vaccine 2015; 33:6277–6281 [View Article][PubMed]
     [Google Scholar]
  20. Hegerle N, Dore G, Guiso N. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine. Vaccine 2014; 32:6597–6600 [View Article][PubMed]
     [Google Scholar]
  21. Bodilis H, Guiso N. Virulence of pertactin-negative Bordetella pertussis isolates from infants, France. Emerg Infect Dis 2013; 19:471–474 [View Article][PubMed]
     [Google Scholar]
  22. Clarke M, McIntyre PB, Blyth CC, Wood N, Octavia S et al. The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis. J Infect 2016; 72:171–178 [View Article][PubMed]
     [Google Scholar]
  23. Tunisian Ministry of Health National Immunization Program, Tunisia. Tunis:: Tunisian Ministry of Health;; 2014. www.santetunisie.rns.tn/images/articles/calend-vaccination2014.pdf
     [Google Scholar]
  24. UNICEF The Multiple Indicator Cluster Survey MICS4 Tunis: UNICEF Tunisie;; 2013 www.unicef.org.tn/medias/MICS4-Fr.pdf
     [Google Scholar]
  25. Zouari A, Smaoui H, Brun D, Njamkepo E, Sghaier S et al. Prevalence of Bordetella pertussis and Bordetella parapertussis infections in Tunisian hospitalized infants: results of a 4-year prospective study. Diagn Microbiol Infect Dis 2012; 72:303–317 [View Article][PubMed]
     [Google Scholar]
  26. André P, Caro V, Njamkepo E, Wendelboe AM, van Rie A et al. Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007. J Clin Microbiol 2008; 46:1672–1677 [View Article][PubMed]
     [Google Scholar]
  27. Tatti KM, Sparks KN, Boney KO, Tondella ML. Novel multitarget real-time PCR assay for rapid detection of Bordetella species in clinical specimens. J Clin Microbiol 2011; 49:4059–4066 [View Article][PubMed]
     [Google Scholar]
  28. Guiso N, von Konig CH, Becker C, Hallander H. Fimbrial typing of Bordetella pertussis isolates: agglutination with polyclonal and monoclonal antisera. J Clin Microbiol 2001; 39:1684–1685 [View Article][PubMed]
     [Google Scholar]
  29. Weber C, Boursaux-Eude C, Coralie G, Caro V, Guiso N. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J Clin Microbiol 2001; 39:4396–4403 [View Article][PubMed]
     [Google Scholar]
  30. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403–410 [View Article][PubMed]
     [Google Scholar]
  31. Tsang RS, Lau AK, Sill ML, Halperin SA, van Caeseele P et al. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol 2004; 42:5364–5367 [View Article][PubMed]
     [Google Scholar]
  32. Muloiwa R, Dube FS, Nicol MP, Zar HJ, Hussey GD. Incidence and diagnosis of pertussis in South African children hospitalized with lower respiratory tract infection. Pediatr Infect Dis J 2016; 35:611–616 [View Article][PubMed]
     [Google Scholar]
  33. Jusot V, Aberrane S, Alé F, Laouali B, Moussa I et al. Prevalence of Bordetella infection in a hospital setting in Niamey, Niger. J Trop Pediatr 2014; 60:223–230 [View Article][PubMed]
     [Google Scholar]
  34. Kayina V, Kyobe S, Katabazi FA, Kigozi E, Okee M et al. Pertussis prevalence and its determinants among children with persistent cough in urban Uganda. PLoS One 2015; 10:e0123240 [View Article][PubMed]
     [Google Scholar]
  35. Bonmarin I, Lévy-Bruhl D, Baron S, Guiso N, Njamkepo E et al. Pertussis surveillance in French hospitals: results from a 10 year period. Eurosurveillance 2007; 12:11–12 [View Article]
     [Google Scholar]
  36. Heininger U, Kleemann WJ, Cherry JD. A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants. Pediatrics 2004; 114:e9e15 [View Article][PubMed]
     [Google Scholar]
  37. Zouari A, Smaoui H, Bousnina S, Menif K, Ben Jaballah N et al. The new health legacy: when pertussis becomes a heritage transmitted from mothers to infants. J Med Microbiol 2011; 60:1546–1549 [View Article][PubMed]
     [Google Scholar]
  38. Ben Fraj I, Smaoui H, Zghal M, Sassi O, Guiso N et al. Seroprevalence of pertussis among healthcare workers: A cross-sectional study from Tunisia. Vaccine 2018 [View Article][PubMed]
     [Google Scholar]
  39. Guiso N. Bordetella pertussis. In Tang Y-W, Sussman M, Liu D, Poxton I, Schwartzman J et al. (editors) Molecular Medical Microbiology, 2nd edn. Boston: Academic Press;; 2014 pp. 1507–1527
     [Google Scholar]
  40. Wendelboe AM, van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24:S58–S61 [View Article][PubMed]
     [Google Scholar]
  41. Katfy K, Guiso N, Diawara I, Zerouali K, Slaoui B et al. Epidemiology of pertussis in Casablanca (Morocco): contribution of conventional and molecular diagnosis tools. BMC Infect Dis 2017; 17:348 [View Article][PubMed]
     [Google Scholar]
  42. Benamrouche N, Tali Maamar H, Lazri M, Hasnaoui S, Radoui A et al. Pertussis in north-central and northwestern regions of Algeria. J Infect Dev Ctries 2016; 10:1191–1199 [View Article][PubMed]
     [Google Scholar]
  43. Hegerle N, Guiso N. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines. Expert Rev Vaccines 2014; 13:1135–1146 [View Article][PubMed]
     [Google Scholar]
  44. Hegerle N, Guiso N. Epidemiology of whooping cough & typing of Bordetella pertussis . Future Microbiol 2013; 8:1391–1403 [View Article][PubMed]
     [Google Scholar]
  45. Bailon H, León-Janampa N, Padilla C, Hozbor D. Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012. BMC Infect Dis 2016; 16:422 [View Article][PubMed]
     [Google Scholar]
  46. Bottero D, Griffith MM, Lara C, Flores D, Pianciola L et al. Bordetella holmesii in children suspected of pertussis in Argentina. Epidemiol Infect 2013; 141:714–717 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000892
Loading
Pertussis epidemiology in Tunisian infants and children and characterization of Bordetella pertussis isolates: results of a 9-year surveillance study, 2007 to 2016
J. Med. Microbiol. 68, 241 (2019); https://doi.org/10.1099/jmm.0.000892
/content/journal/jmm/10.1099/jmm.0.000892
/content/journal/jmm/10.1099/jmm.0.000892
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error